Active SLE patients as compared to inactive SLE patients were not different regarding the BTLA expression on CD4+CD25++CD127− regulatory T-cells (27.5% ± 13.4% vs. 31.7% ± 11.9%, p = 0.41). The gene discussed is CD4; the disease is systemic lupus erythematosus.